At 05:25 3/4/01 -0700, Simeon Fitch wrote: > >--- Peter Donald <[EMAIL PROTECTED]> wrote: >> At 06:02 30/3/01 -0800, Simeon Fitch wrote: >> >The voiced sentiment appears to be that: a) a move to expand the >> committer >> >pool for Antidote is needed, b) a separate CVS module for Andiote would >> be >> >beneficial, and c) having separate Ant and Antidote committer groups is >> >*not* necessary. >> > >> >Therefore, I'm calling for a vote on creating a new CVS module called >> >"jakarta-ant-antidote" where the code currently located at >> >"jakarta-ant/src/antidote" will live. >> >> +1 >> >> <snip> > >> > >> >(If there are no vetos, who needs to be contacted to create and setup >> the >> >new module?) >> >> Any committer can do it by reading /home/cvs/README - since your lead >> .... > >Sorry for the handholding, but step "(a)" in the README is "Get permission >from your PMC." Where do I send such email to get permission (I can't seem >to find it under the mailing list section of the web site).
Well I assume you have permission as at least four PMC members are on this list and haven't vetoed it ;) I put that condition in just as a precaution so that that no excessive repositories get created but mostly the philosophy is to push down the power to the committers. For future reference you can contact the PMC via either [email protected] (preferred) or [EMAIL PROTECTED] (if the question requires discretion) Cheers, Pete *-----------------------------------------------------* | "Faced with the choice between changing one's mind, | | and proving that there is no need to do so - almost | | everyone gets busy on the proof." | | - John Kenneth Galbraith | *-----------------------------------------------------*
